AF
BNTX icon

Arrow Financial’s BioNTech BNTX Stock Holding History

Arrow Financial’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-50
Closed -$5.43K – 350
2023
Q3 		$5.43K Hold
50
– – ﹤0.01% 305
2023
Q2 		$5.4K Hold
50
– – ﹤0.01% 290
2023
Q1 		$6.23K Hold
50
– – ﹤0.01% 292
2022
Q4 		$8K Hold
50
– – ﹤0.01% 289
2022
Q3 		$7K Hold
50
– – ﹤0.01% 296
2022
Q2 		$7K Hold
50
– – ﹤0.01% 305
2022
Q1 		$9K Hold
50
– – ﹤0.01% 302
2021
Q4 		$13K Hold
50
– – ﹤0.01% 278
2021
Q3 		$14K Hold
50
– – ﹤0.01% 274
2021
Q2 		$11K Hold
50
– – ﹤0.01% 285
2021
Q1 		$5K Hold
50
– – ﹤0.01% 298
2020
Q4 		$4K Buy
+50
New +$4.91K ﹤0.01% 293

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Arrow Financial's BNTX Position: Q4 2023 in Review

Arrow Financial sold out of BioNTech (BNTX) in Q4 2023, closing a stake of 50 shares — an estimated $5.43K sold.

Arrow Financial first reported a position in BNTX in Q4 2020 and held it in 12 quarters. The position peaked at $14K in Q3 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q4 2023.

  • Arrow Financial reported no remaining BioNTech position as of Q4 2023 after selling out during the quarter.
  • Arrow Financial sold 50 BioNTech shares in Q4 2023, an estimated $5.43K.
  • Arrow Financial first reported a position in BioNTech in Q4 2020 and held it in 12 quarters.
  • Arrow Financial's BioNTech position peaked at $14K in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q4 2023.

Based on Arrow Financial's 13F filing for Q4 2023, filed 12 Feb 2024.